<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kramer B</submitter><funding>National Institute for Health Research (NIHR)</funding><funding>Wellcome Trust</funding><funding>Academy of Medical Sciences</funding><pagination>2650-2669.e14</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8416549</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>54(11)</volume><pubmed_abstract>Longitudinal analyses of the innate immune system, including the earliest time points, are essential to understand the immunopathogenesis and clinical course of coronavirus disease (COVID-19). Here, we performed a detailed characterization of natural killer (NK) cells in 205 patients (403 samples; days 2 to 41 after symptom onset) from four independent cohorts using single-cell transcriptomics and proteomics together with functional studies. We found elevated interferon (IFN)-α plasma levels in early severe COVD-19 alongside increased NK cell expression of IFN-stimulated genes (ISGs) and genes involved in IFN-α signaling, while upregulation of tumor necrosis factor (TNF)-induced genes was observed in moderate diseases. NK cells exert anti-SARS-CoV-2 (severe acute respiratory syndrome coron</pubmed_abstract><journal>Immunity</journal><pubmed_title>Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19.</pubmed_title><pmcid>PMC8416549</pmcid><funding_grant_id>CL-2015-01-002</funding_grant_id><funding_grant_id>SGL015\1021</funding_grant_id><funding_grant_id>214539/Z/18/Z</funding_grant_id><funding_grant_id>ACF-2020-01-007</funding_grant_id><pubmed_authors>Ludwig KU</pubmed_authors><pubmed_authors>Haniffa M</pubmed_authors><pubmed_authors>Franzenburg S</pubmed_authors><pubmed_authors>Stephenson E</pubmed_authors><pubmed_authors>Schiffer P</pubmed_authors><pubmed_authors>von Kleist M</pubmed_authors><pubmed_authors>Nattermann J</pubmed_authors><pubmed_authors>Boyke B</pubmed_authors><pubmed_authors>McHardy AC</pubmed_authors><pubmed_authors>Bitzer M</pubmed_authors><pubmed_authors>Wieczorek D</pubmed_authors><pubmed_authors>Goldman J</pubmed_authors><pubmed_authors>Hrusovsky K</pubmed_authors><pubmed_authors>Koenig PA</pubmed_authors><pubmed_authors>Keppler OT</pubmed_authors><pubmed_authors>Reusch N</pubmed_authors><pubmed_authors>Su Y</pubmed_authors><pubmed_authors>Gopel S</pubmed_authors><pubmed_authors>Sharaf ML</pubmed_authors><pubmed_authors>Landthaler M</pubmed_authors><pubmed_authors>Vogel J</pubmed_authors><pubmed_authors>Gauder M</pubmed_authors><pubmed_authors>Hubschmann D</pubmed_authors><pubmed_authors>Fischer N</pubmed_authors><pubmed_authors>Horn F</pubmed_authors><pubmed_authors>Sczyrba A</pubmed_authors><pubmed_authors>Blumert C</pubmed_authors><pubmed_authors>Walter J</pubmed_authors><pubmed_authors>Korbel J</pubmed_authors><pubmed_authors>Yuan D</pubmed_authors><pubmed_authors>Keller A</pubmed_authors><pubmed_authors>Kramer B</pubmed_authors><pubmed_authors>Ulas T</pubmed_authors><pubmed_authors>Colome-Tatche M</pubmed_authors><pubmed_authors>Kim-Hellmuth S</pubmed_authors><pubmed_authors>Nunes da Rocha U</pubmed_authors><pubmed_authors>Hanses F</pubmed_authors><pubmed_authors>Monin MB</pubmed_authors><pubmed_authors>Kohlbacher O</pubmed_authors><pubmed_authors>Scheithauer S</pubmed_authors><pubmed_authors>Schlabe S</pubmed_authors><pubmed_authors>Strassburg CP</pubmed_authors><pubmed_authors>Stegle O</pubmed_authors><pubmed_authors>Hoffmeister C</pubmed_authors><pubmed_authors>Pink I</pubmed_authors><pubmed_authors>Rieß O</pubmed_authors><pubmed_authors>Volland S</pubmed_authors><pubmed_authors>Hack G</pubmed_authors><pubmed_authors>Diefenbach A</pubmed_authors><pubmed_authors>Nischalke HD</pubmed_authors><pubmed_authors>Kuhnert D</pubmed_authors><pubmed_authors>Keitel V</pubmed_authors><pubmed_authors>Kallies R</pubmed_authors><pubmed_authors>Heath JR</pubmed_authors><pubmed_authors>Kurth I</pubmed_authors><pubmed_authors>Gabernet G</pubmed_authors><pubmed_authors>Raabe J</pubmed_authors><pubmed_authors>Kurth F</pubmed_authors><pubmed_authors>Kaiser KM</pubmed_authors><pubmed_authors>Rajewsky N</pubmed_authors><pubmed_authors>Schneider W</pubmed_authors><pubmed_authors>Nothen M</pubmed_authors><pubmed_authors>Theis F</pubmed_authors><pubmed_authors>ToVinh M</pubmed_authors><pubmed_authors>Sonnabend M</pubmed_authors><pubmed_authors>Makarewicz O</pubmed_authors><pubmed_authors>Gardner L</pubmed_authors><pubmed_authors>Overmann J</pubmed_authors><pubmed_authors>Poetsch AR</pubmed_authors><pubmed_authors>Goesmann A</pubmed_authors><pubmed_authors>Klein C</pubmed_authors><pubmed_authors>Schmidt SV</pubmed_authors><pubmed_authors>Hoeper M</pubmed_authors><pubmed_authors>Schmid-Burgk J</pubmed_authors><pubmed_authors>Janssen S</pubmed_authors><pubmed_authors>Saliba AE</pubmed_authors><pubmed_authors>Latz E</pubmed_authors><pubmed_authors>Ganzenmueller T</pubmed_authors><pubmed_authors>Sander LE</pubmed_authors><pubmed_authors>Winkler S</pubmed_authors><pubmed_authors>Bluthgen N</pubmed_authors><pubmed_authors>Singh Y</pubmed_authors><pubmed_authors>Vehreschild J</pubmed_authors><pubmed_authors>Knoll R</pubmed_authors><pubmed_authors>Heimbach A</pubmed_authors><pubmed_authors>Schultze JL</pubmed_authors><pubmed_authors>Handler K</pubmed_authors><pubmed_authors>Kummerer BM</pubmed_authors><pubmed_authors>Schmidt FI</pubmed_authors><pubmed_authors>Reynolds G</pubmed_authors><pubmed_authors>Deutsche COVID-19 OMICS Initiative (DeCOI)</pubmed_authors><pubmed_authors>Bonifacio E</pubmed_authors><pubmed_authors>Hummel M</pubmed_authors><pubmed_authors>Ralser M</pubmed_authors><pubmed_authors>Kehr B</pubmed_authors><pubmed_authors>Munchhoff M</pubmed_authors><pubmed_authors>Bezdan D</pubmed_authors><pubmed_authors>Kohrer K</pubmed_authors><pubmed_authors>Protzer U</pubmed_authors><pubmed_authors>Iftner A</pubmed_authors><pubmed_authors>Rosenstiel P</pubmed_authors><pubmed_authors>Johnson JM</pubmed_authors><pubmed_authors>Schulte EC</pubmed_authors><pubmed_authors>Stoye J</pubmed_authors><pubmed_authors>Schulte-Schrepping J</pubmed_authors><pubmed_authors>Chen D</pubmed_authors><pubmed_authors>Geißert J</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Casadei N</pubmed_authors><pubmed_authors>Kalinowski J</pubmed_authors><pubmed_authors>Grundhoff A</pubmed_authors><pubmed_authors>Ossowski S</pubmed_authors><pubmed_authors>Iftner T</pubmed_authors><pubmed_authors>Cornberg M</pubmed_authors><pubmed_authors>Rieke GJ</pubmed_authors><pubmed_authors>Hehr U</pubmed_authors><pubmed_authors>Peter S</pubmed_authors><pubmed_authors>Gagneur J</pubmed_authors><pubmed_authors>Becker M</pubmed_authors><pubmed_authors>Stubbemann P</pubmed_authors><pubmed_authors>De La Rosa Velazquez IA</pubmed_authors><pubmed_authors>Puhler A</pubmed_authors><pubmed_authors>Bartholomaus A</pubmed_authors><pubmed_authors>Frick JS</pubmed_authors><pubmed_authors>Ball AJ</pubmed_authors><pubmed_authors>Jensen B</pubmed_authors><pubmed_authors>Illig T</pubmed_authors><pubmed_authors>Ripke S</pubmed_authors><pubmed_authors>Nurnberg P</pubmed_authors><pubmed_authors>Velavan TP</pubmed_authors><pubmed_authors>Reiche K</pubmed_authors><pubmed_authors>Walker A</pubmed_authors><pubmed_authors>Hain T</pubmed_authors><pubmed_authors>Marz M</pubmed_authors><pubmed_authors>Bischoff J</pubmed_authors><pubmed_authors>Altmuller J</pubmed_authors><pubmed_authors>Clavel T</pubmed_authors><pubmed_authors>Forstner K</pubmed_authors><pubmed_authors>Grundmann H</pubmed_authors><pubmed_authors>Mertes C</pubmed_authors><pubmed_authors>Ziebuhr J</pubmed_authors><pubmed_authors>Blum H</pubmed_authors><pubmed_authors>De Domenico E</pubmed_authors><pubmed_authors>Bork P</pubmed_authors><pubmed_authors>Finnemann C</pubmed_authors><pubmed_authors>Aschenbrenner AC</pubmed_authors><pubmed_authors>Angelov A</pubmed_authors><pubmed_authors>Knop M</pubmed_authors><pubmed_authors>Pfeffer K</pubmed_authors><pubmed_authors>Bals R</pubmed_authors><pubmed_authors>Ntoumi F</pubmed_authors><pubmed_authors>Astaburuaga-Garcia R</pubmed_authors><pubmed_authors>Bonaguro L</pubmed_authors><pubmed_authors>Sawitzki B</pubmed_authors><pubmed_authors>Dilthey A</pubmed_authors><pubmed_authors>Marini F</pubmed_authors><pubmed_authors>Kremsner PG</pubmed_authors><pubmed_authors>Nahnsen S</pubmed_authors><pubmed_authors>Becker A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19.</name><description>Longitudinal analyses of the innate immune system, including the earliest time points, are essential to understand the immunopathogenesis and clinical course of coronavirus disease (COVID-19). Here, we performed a detailed characterization of natural killer (NK) cells in 205 patients (403 samples; days 2 to 41 after symptom onset) from four independent cohorts using single-cell transcriptomics and proteomics together with functional studies. We found elevated interferon (IFN)-α plasma levels in early severe COVD-19 alongside increased NK cell expression of IFN-stimulated genes (ISGs) and genes involved in IFN-α signaling, while upregulation of tumor necrosis factor (TNF)-induced genes was observed in moderate diseases. NK cells exert anti-SARS-CoV-2 (severe acute respiratory syndrome coron</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2026-05-08T00:43:42.455Z</modification><creation>2022-02-11T13:14:22.691Z</creation></dates><accession>S-EPMC8416549</accession><cross_references><pubmed>34592166</pubmed><doi>10.1016/j.immuni.2021.09.002</doi></cross_references></HashMap>